Volume 78, Issue 5, Pages (September 2010)

Slides:



Advertisements
Similar presentations
Improved prognosis of diabetic nephropathy in type 1 diabetes
Advertisements

Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody– associated vasculitis  Shen-Ju Gou, Jun Yuan, Min Chen, Feng Yu,
Volume 81, Issue 2, Pages (January 2012)
Volume 65, Issue 1, Pages (January 2004)
Volume 74, Issue 12, Pages (December 2008)
Lymphatic vessels develop during tubulointerstitial fibrosis
Volume 70, Issue 10, Pages (November 2006)
Renal manifestations in Fabry disease and therapeutic options
A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use  Mei-Ling Blank, Lianne.
Volume 66, Issue 1, Pages (July 2004)
Volume 68, Issue 6, Pages (December 2005)
Volume 85, Issue 4, Pages (April 2014)
Histologic classification of glomerular diseases: clinicopathologic correlations, limitations exposed by validation studies, and suggestions for modification 
Volume 88, Issue 4, Pages (October 2015)
Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody– associated vasculitis  Shen-Ju Gou, Jun Yuan, Min Chen, Feng Yu,
Volume 76, Issue 5, Pages (September 2009)
Volume 65, Issue 1, Pages (January 2004)
Volume 74, Issue 12, Pages (December 2008)
Volume 80, Issue 10, Pages (November 2011)
Volume 84, Issue 2, Pages (August 2013)
Kumar Sharma, Ljiljana Paša-Tolić  Kidney International 
JAK/STAT signaling in renal diseases
Volume 78, Issue 2, Pages (July 2010)
Tubular NF-κB and AP-1 activation in human proteinuric renal disease
Volume 86, Issue 6, Pages (December 2014)
Glomerular filtration: the charge debate charges ahead
Volume 93, Issue 1, (January 2018)
Tubular biomarkers to assess progression of diabetic nephropathy
Volume 88, Issue 5, Pages (November 2015)
Volume 57, Issue 2, Pages (October 2000)
Volume 75, Issue 12, Pages (June 2009)
Serum-soluble urokinase receptor concentration in primary FSGS
Volume 68, Issue 6, Pages (December 2005)
Volume 63, Issue 4, Pages (April 2003)
HIV-associated immune complex glomerulonephritis with “lupus-like” features: A clinicopathologic study of 14 cases1  Mark Haas, Sadhana Kaul, Joseph A.
Volume 80, Issue 2, Pages (July 2011)
Yongji Wang, Megan L. Borchert, Hector F. DeLuca  Kidney International 
Lymphatic vessels develop during tubulointerstitial fibrosis
Volume 55, Issue 2, Pages (February 1999)
Volume 67, Issue 1, Pages (January 2005)
Volume 73, Issue 11, Pages (June 2008)
Volume 95, Issue 3, Pages (March 2019)
Tarak Srivastava, Robert E. Garola, Joan M. Whiting, Uri S. Alon 
The Case ∣ Fever, rash, and positive Ehrlichia antibodies
Local macrophage proliferation in human glomerulonephritis
Synaptopodin expression in idiopathic nephrotic syndrome of childhood
Volume 76, Issue 5, Pages (September 2009)
Volume 61, Issue 1, Pages (January 2002)
Expression of connective tissue growth factor in human renal fibrosis
Mitochondrial dysfunction in focal segmental glomerulosclerosis of puromycin aminonucleoside nephrosis  M. Hagiwara, K. Yamagata, R.A. Capaldi, A. Koyama 
The Case | Idiopathic hypocomplementemic interstitial nephritis
Volume 72, Issue 12, Pages (December 2007)
IgG4-related tubulointerstitial nephritis
Kick it up a notch: Notch signaling and kidney fibrosis
Volume 67, Issue 3, Pages (March 2005)
Calcium sensing in podocytes
Volume 71, Issue 7, Pages (April 2007)
Improved prognosis of diabetic nephropathy in type 1 diabetes
Volume 58, Issue 5, Pages (November 2000)
Volume 73, Issue 5, Pages (March 2008)
Overview of the cellular and molecular basis of kidney fibrosis
Accelerated expression of senescence associated cell cycle inhibitor p16INK4A in kidneys with glomerular disease  B. Sis, A. Tasanarong, F. Khoshjou,
The Danish Renal Biopsy Register
Fig. 1 Intrarenal lymphangiogenesis in patients with CKD accompanied by intrarenal inflammatory cells and renal fibrosis. Intrarenal lymphangiogenesis.
Membranous nephropathy: recent travels and new roads ahead
The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?  Richard E. Gilbert, Mark E. Cooper  Kidney.
Volume 79, Issue 10, Pages (May 2011)
Renoprotection with vitamin D: Specific for diabetic nephropathy?
Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  Lei-Shi Li, Zhi-Hong Liu  Kidney International 
Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis  Eero O. Honkanen, Anna-Maija Teppo, Carola.
Presentation transcript:

Volume 78, Issue 5, Pages 514-522 (September 2010) Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function  Mariana Murea, Jun-Ki Park, Shuchita Sharma, Hideki Kato, Antje Gruenwald, Thiruvur Niranjan, Han Si, David B. Thomas, James M. Pullman, Michal L. Melamed, Katalin Susztak  Kidney International  Volume 78, Issue 5, Pages 514-522 (September 2010) DOI: 10.1038/ki.2010.172 Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 1 Expression of Notch molecules in control human kidney. Double immunostaining of a single control (healthy) human kidney sample with WT-1 (a–d) (fluorescein isothiocyanate; green) and cleaved Notch1 (a), and Notch2 (b), Jagged1 (c) or Delta1 (d) (Cy3; red), nuclear stain with 4’,6-diamidino-2-phenylindole (blue) or their combination shown as indicated on the figure. glom, glomerulus. Kidney International 2010 78, 514-522DOI: (10.1038/ki.2010.172) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 2 Expression of Notch molecules in diseased human kidney biopsy sample. Double immunostaining from a single diseased human kidney sample with WT-1 (fluorescein isothiocyanate; green) and cleaved Notch1 (a), and Notch2 (b), Jagged1 (c) or Delta1 (d) (Cy3; red) nuclear stain with 4’,6-diamidino-2-phenylindole (blue) as indicated on the figure. The pictures were taken from a single case of membranous nephropathy. Kidney International 2010 78, 514-522DOI: (10.1038/ki.2010.172) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 3 Glomerular-specific expression of cleaved Notch1, 2 and Jagged1 in different renal disease groups. The relative expression of active Notch1 (blue bar), Notch2 (red bar) and Jagged1 (yellow bar) in the glomerulus was scored in each biopsy sample. The graph shows the mean and s.d. of the expression of each molecule. *denotes statistically significant differences (P<0.05) when compared with controls. Cresc, crescentic; DNP, diabetic nephropathy; FSGS, focal segmental glomerulosclerosis; HN, hypertensive nephrosclerosis; IgAN, immunoglobulin A nephropathy; IMN, idiopathic membranous nephropathy; LN, lupus nephritis; MCD, minimal change disease. Kidney International 2010 78, 514-522DOI: (10.1038/ki.2010.172) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 4 Tubulointerstitial expression of cleaved Notch1, 2, Jagged1 and Delta1 in different renal disease groups. The relative expression of active Notch1 (blue bar), Notch2 (red bar), Jagged1 (yellow bar) and Delta1 (light blue bar) in the tubulointerstitium was scored in each biopsy sample. The graph shows the mean and s.d. of the expression of each molecule. *denotes statistically significant differences (P<0.05) when compared with controls. Cresc, crescentic; FSGS, focal segmental glomerulosclerosis; HN, hypertensive nephrosclerosis; IgAN, immunoglobulin A nephropathy; IMN, idiopathic membranous nephropathy; LN, lupus nephritis; MCD, minimal change disease. Kidney International 2010 78, 514-522DOI: (10.1038/ki.2010.172) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 5 Correlation plots of podocyte Notch1 expression and glomerulosclerosis and tubulointerstitial fibrosis and tubulointerstitial expression of active Notch1. Scatter plot with fitted values (red line) and 95% confidence (green line) intervals for (a) percent glomerulosclerosis and podocyte expression of Notch1 and (b) and tubular expression of Notch1 and tubulointerstitial fibrosis. Kidney International 2010 78, 514-522DOI: (10.1038/ki.2010.172) Copyright © 2010 International Society of Nephrology Terms and Conditions